CNS Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.
Trademark Applications
Trademark applications show the products and services that CNS Therapeutics is developing and marketing.
CNS Therapeutics doesn't have any recent trademark applications, indicating CNS Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
INGENUITY. PURE AND SIMPLE. Pharmaceutical preparations for the treatment of spasticity; pharmaceutical kits comprised of pharmaceutical preparations for the treatment of spasticity; intrathecal systems comprised of pharmaceutical preparations for the treatment of spasticity
05/05/2010
GABLOFEN Pharmaceutical preparations for the treatment of spasticity; pharmaceutical kits comprised of pharmaceutical preparations for the treatment of spasticity; intrathecal systems comprised of pharmaceutical preparations for the treatment of spasticity
10/16/2009
CNS THERAPEUTICS Dispensing of pharmaceuticals
09/02/2009
See all trademarks and details in the Full Report.
Market Share of CNS Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as CNS Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to CNS Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as CNS Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.